Key result
Expanded CD34+ EPC-derived cells promote vascularization and improve left ventricular function after myocardial infarction.
Answers are grounded in this paper and cite their sources.
Mobilization and recruitment of endothelial progenitor cells (EPC) contributes to vasculogenesis in vivo. So far, applications for cell therapy are limited by the number of available cells. Expansion of EPC or their progeny may, therefore, facilitate its therapeutic use in ischemic disease. The aim of this study was to expand CD34+ EPC-derived progeny from different sources, characterize them, and investigate their potential for use in therapeutic vasculogenesis. CD34+ cells from G-CSF-mobilized peripheral blood (PB) and cord blood (CB) were isolated using immunomagnetic beads and cultured in endothelial cell medium. Cells were expanded up to 16 (PB) and up to 46 (CB) population doublings, respectively. Immunophenotypic and mRNA expression analyses showed a high degree of similarity between the cultured cells and human umbilical vein endothelial cells (HUVEC). By day 14 after transplantation, transplanted human CD31-positive EPC-derived cells were detected. These cells expressed the proliferation marker Ki67 and formed vessel-like structures in ischemic myocardium. Most strikingly, transplantation of EPC-derived cells improved left ventricular function after experimental ischemia, as shown by echocardiography. In conclusion, cells cultured from CD34+ EPC can be expanded in vitro to clinically relevant numbers. In vivo, these cells proliferate, form vascular structures, and improve left ventricular function after experimental myocardial infarction. Therefore, in vitro expanded EPC-derived endothelial cells may be beneficial in the treatment of ischemic disease.
No takes yet. Share an insight, caveat, or question.
Ott et al. (2005) studied Experimental myocardial infarction / ischemic disease. Transplantation of in vitro expanded CD34+ EPC-derived endothelial-like cells was evaluated on Left ventricular function and formation of vessel-like structures in ischemic myocardium. CD34+ EPC-derived cells expanded up to 46 population doublings formed vessel-like structures by day 14 and improved left ventricular function after experimental myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: